logo
Plus   Neg
Share
Email

Ford Q2 U.S. Sales Down 33.3%

Ford Motor Co. (F) said Thursday that its total sales for the second-quarter declined 33.3 percent, hurt by the ongoing global COVID-19 pandemic.

The company's retail was down much less than industry at 14.3 percent, the company said in a statement.

Ford's U.S. sales for the second-quarter declined 33.3 percent to 433,869 vehicles from 650,336 vehicles last year.

Car sales for the quarter dropped 59.5 percent year-over-year to 44,650 units from 110,195 units, while truck sales also decreased 26.6 percent to 237,891 units and SUVs sales declined 29.9 percent to 151,328 units as compared to a year earlier.

U.S. vehicle sales for major companies fell sharply in the second-quarter.

On Wednesday, General Motors said that it delivered 492,489 vehicles in the second quarter of 2020, a decrease of about 34 percent from last year, reflecting Covid-19 pandemic's effect on demand and tight inventories.

Nissan Group reported that total U.S. sales for the second-quarter were 177,328 units, a decrease of 49.5 percent from the prior year.

Meanwhile, Volkswagen of America reported that its second-quarter total sales dropped 29 percent to 69,933 vehicles from 98,736 vehicles in the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273. The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year.
Follow RTT